Alert detail
FDA Approval: TRODELVY (SACITUZUMAB GOVITECAN) — Type 1 - New Molecular Entity
Policy ID: FDA-BLA761115Specialty: Multi-specialtyAdded: 6/27/2026Effective: 2020-04-22billing update
Full alert analysis requires a subscription
Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.